Clinical Trial Update: Combination Chemotherapy With or Without Bevacizumab in Treating Patients With Nonmetastatic Breast Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating combination chemotherapy with or without bevacizumab for nonmetastatic breast cancer. The current status is listed as UNKNOWN.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Bevacizumab (bevacizumab)

Snippet

Sponsor: Cambridge University Hospitals NHS Foundation Trust | Conditions: Breast Cancer, Cardiac Toxicity | Phase 3 | Status: UNKNOWN